How to Check Phychem Technologies IPO Allotment Status

Phychem Technologies Limited is engaged in the manufacture of rotational moulding compounds, which are used as raw materials for producing hollow plastic products through the rotational moulding process. Its products find applications across sectors including building and construction, water management, agriculture, automotive, marine, furniture, toys, chemicals, sewage and waste processing, and railways.

The company's portfolio includes colour powder compounds, PE foam compounds, stone-effect compounds, flame-retardant compounds, flexible compounds and other customised rotational moulding compounds. It also manufactures custom-moulded tanks and provides rotolining and toll-pulverising services.

Phychem operates from a manufacturing facility at Dindori, Nashik, Maharashtra, equipped with three rotational moulding machines and supporting equipment. In FY26, it had installed roto-moulding compound capacity of 6,000 MT per annum and custom-moulded tank capacity of 2,000 tanks annually.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Phychem Technologies IPO is a ₹14.58 crore book-built BSE SME issue, comprising a fresh issue of 27 lakh equity shares at the upper end of the price band. There is no offer-for-sale component.

The IPO opened for subscription on August 31, 2026 and closed on September 2, 2026. The basis of allotment is scheduled for September 3, 2026, followed by initiation of refunds and credit of shares on September 4. The shares are scheduled to list on BSE SME on September 7, 2026.

The price band was fixed at ₹51 to ₹54 per share, with a lot size of 2,000 shares. Individual Investors are required to apply for at least two lots or 4,000 shares, translating into a minimum investment of ₹2,16,000 at the upper price band.

Hem Securities Limited is the book-running lead manager, while MUFG Intime India Private Limited is the registrar to the issue.

Registrar:  MUFG Intime India Private Limited 

NSE: NSE IPO Allotment Status Page

Phychem Technologies IPO Subscription Status

Phychem Technologies IPO was subscribed 20.47 times by 5:06 PM on September 2, 2026, based on the supplied subscription snapshot. At that point, the public issue had received bids for 3,68,42,000 shares against 18,00,000 shares available for subscription.

The Individual Investor category was subscribed 20.24 times by 5:06 PM on Day 3, compared with 1.38 times on Day 2 and just 0.25 times on the opening day.

The QIB category saw comparatively moderate movement during the issue period. It was subscribed 3.53 times on both Day 1 and Day 2 before increasing to 4.31 times on the final day.

Overall subscription increased from 1.26 times on Day 1 to 1.97 times on Day 2, before reaching 20.47 times in the supplied closing-day snapshot.

Later post-close trackers show slightly different figures. One later snapshot recorded 20.74 times overall, with QIBs at 4.31 times, NIIs at 42.34 times and Individual Investors at 20.69 times. Other exchange-based data showed different calculations for the NII reservation. The table above therefore retains the 20.47-times 5paisa snapshot supplied.

Phychem Technologies IPO Share Price and Investment Details

Phychem Technologies IPO price band was fixed at ₹51 to ₹54 per share, with a lot size of 2,000 shares. Individual Investors are required to apply for at least two lots, or 4,000 shares, resulting in a minimum investment of ₹2,16,000 at the upper price of ₹54.

The IPO comprises 27 lakh fresh shares, aggregating to approximately ₹14.58 crore at the upper price band. There is no OFS component, and the shares are proposed to list on BSE SME.

Based on the supplied subscription snapshot, NIIs led demand at 42.13 times, followed by Individual Investors at 20.24 times and QIBs at 4.31 times. Overall subscription stood at 20.47 times as of the supplied 5:06 PM snapshot.

Given the level of subscription, allotment competition is higher particularly in the NII and Individual Investor categories. The basis of allotment is scheduled for September 3, 2026, ahead of the proposed September 7 listing.

Utilisation of IPO Proceeds

Phychem Technologies proposes to utilise approximately ₹2.50 crore from the IPO proceeds towards the repayment or prepayment of certain outstanding borrowings.

The company proposes to deploy approximately ₹5.15 crore towards capital expenditure for procuring plant and machinery. The planned equipment includes machinery supporting the manufacture of rotational moulding compounds and custom-moulded products at its existing facility.  

Another ₹3 crore is proposed to be utilised towards working-capital requirements, while the balance eligible proceeds are intended for general corporate purposes.  

The capital expenditure is expected to include equipment such as rotational moulding, pulverising and extrusion machinery, supporting capacity and productivity at the company's existing manufacturing facility.  

Since the IPO is structured entirely as a fresh issue, there is no OFS component. Consequently, the net issue proceeds are intended for Phychem Technologies rather than existing selling shareholders.  

Business Overview

Phychem Technologies follows a primarily B2B manufacturing and distribution model. Manufacturing accounted for approximately 92.61% of FY26 operating revenue, while trading contributed around 7.18% and services accounted for the balance.

Its rotational moulding compounds are used to manufacture hollow plastic products such as water and chemical storage tanks, sanitation products, furniture, automotive components and industrial containers. The company's portfolio includes colour compounds, stone-effect compounds, PE foam compounds, flexible compounds, flame-retardant products and other customised formulations.

The company operates a single manufacturing facility in Nashik, Maharashtra, covering approximately 5,100 square metres. Its 6,000 MT annual roto-moulding compound capacity operated at 65.45% utilisation in FY26, while its 2,000-unit custom-moulded tank capacity recorded utilisation of 91.45%.

Phychem has developed a domestic and international customer base. During FY26, it sold products to approximately 265 domestic customers and 24 global customers, with exports contributing 23.32% of revenue from operations. Its products reached around 21 countries, while about 142 customers placed repeat orders over the preceding three years.

The company reported total income of ₹57.48 crore in FY26, compared with ₹51.11 crore in FY25 and ₹47.59 crore in FY24. Profit after tax increased to ₹4.09 crore in FY26, from ₹2.84 crore in FY25 and ₹1.69 crore in FY24.

Key strengths include its diversified rotational moulding compound portfolio, presence across multiple end-user industries, domestic and export customer base, in-house manufacturing capabilities and established relationships with repeat customers. The company also holds ISO 9001:2015 certification and operates a zero-liquid-discharge facility with a ZED Bronze certification.

Investors should also consider risks associated with dependence on a single manufacturing facility, customer and supplier concentration, raw-material price fluctuations, lack of long-term customer and supplier contracts, export-related risks and environmental compliance requirements. Its top ten customers accounted for approximately 52.99% of FY26 revenue, while its largest customer contributed 15.73%. Its largest supplier accounted for more than 62% of FY26 purchases.